Video

Streamlining Relationships Among Specialty Pharmacy Stakeholders

Author(s):

Lauren Santye, Assistant Editor

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses how communication can be improved among specialty pharmacies, manufacturers, and pharmacy benefit managers.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses how communication can be improved among specialty pharmacies, manufacturers, and pharmacy benefit managers.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Related Content
FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
August 19th 2025

FDA Issues CRL to Vatiquinone NDA Indicated For Friedreich Ataxia

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
August 19th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Bleeding stroke brain artery, Cellular structure with intricate connections and a vibrant red nucleus, representing biological elements.
August 19th 2025

Atorvastatin Improves Outcomes, LDL-C Following Pipeline Therapy for Intracranial Aneurysms

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
August 19th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Sunvozertinib Brings Changes in Non-Small Cell Lung Cancer Treatment
August 19th 2025

Sunvozertinib Brings Changes in Non-Small Cell Lung Cancer Treatment

Amy C. Nieto, BS, PharmD Candidate
Dynamic 3D Visualization of Cholesterol Lowering Process in Bloodstream
August 19th 2025

Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning

Luke Halpern, Assistant Editor